| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-08 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.3 | 1e-07 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |